Efficacy And Safety Of Pozelimab And Cemdisiran Combination Therapy In Patients With Symptomatic Generalized Myasthenia Gravis
Posted Date: Nov 12, 2021
- Investigator: Hani Kushlaf
- Specialties:
- Type of Study: Drug
The primary objective of the study is to evaluate the effect of pozelimab + cemdisiran on daily functioning that is impacted by signs and symptoms in patients with symptomatic generalized myasthenia gravis (gMG).
Criteria:
Null
Keywords:
Myasthenia Gravis, Mg
For More Information:
Ashley Smith
513-558-4874
ashley.fisher@uc.edu